Chongqing Zhifei Biological Products Co., Ltd. (SHE:300122)

Market Cap	29.23B -37.5%
Revenue (ttm)	8.75B -48.5%
Net Income	-14.78B
EPS	-6.18
Shares Out	2.39B
PE Ratio	n/a
Forward PE	9.42
Dividend	n/a
Ex-Dividend Date	n/a

Volume	25,433,451
Open	12.36
Previous Close	12.61
Day's Range	12.20 - 12.69
52-Week Range	11.77 - 26.00
Beta	0.53
Analysts	Hold
Price Target	21.90 (+79.36%)
Earnings Date	Aug 28, 2026

About SHE:300122

Chongqing Zhifei Biological Products Co., Ltd., a biopharmaceutical company, engages in the research and development, production, sale, and distribution of vaccine and biological products in China. The company offers recombinant COVID-19 vaccine; recombinant mycobacterium tuberculosis fusion protein products; group A and C meningococcal polysaccharide vaccine; ACYW135 meningococcal polysaccharide vaccine; Haemophilus Influenza type B conjugate vaccine; mycobacterium injection under the Vaccae brand; and meningococcal group A and C conjugate vac...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2002
• Employees: 6,292
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300122

Analyst Summary

According to 5 analysts, the average rating for 300122 stock is "Hold." The 12-month stock price target is ¥21.90, which is an increase of 79.36% from the latest price.

Price Target

¥21.90

(79.36% upside)

Analyst Consensus: Hold

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 19, 2026

Data Sources Report a data error